KK

Kunhabdulla Kannipoyil Meethal

Active Director Director DIN 09273554
DIN 09273554 First appointment Aug 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Kunhabdulla Kannipoyil Meethal

Data last updated:

Kunhabdulla Kannipoyil Meethal is a Director at Carpel Healthcare Private Limited (since 2021). The company operates in Healthcare.

DIN 09273554
Primary Designation Director
Industry Healthcare
First Appointment 13 Aug 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Carpel Healthcare Private Limited U85110KL2021PTC070371
Director13 Aug 20212021Active

Board colleagues of Kunhabdulla Kannipoyil Meethal

Directorship timeline

Open interactive timeline →
Carpel Healthcare Private Limited
Premium access

Shareholding and investment profile for Kunhabdulla Kannipoyil Meethal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kunhabdulla Kannipoyil Meethal

Kunhabdulla Kannipoyil Meethal currently holds 1 directorship: Carpel Healthcare Private Limited (Director, since 13 Aug 2021).

Kunhabdulla Kannipoyil Meethal was first appointed on 13 Aug 2021 as Director at Carpel Healthcare Private Limited.

The current boards of Kunhabdulla Kannipoyil Meethal's companies include Abdul Jaleel Eramangalath (Carpel Healthcare Private Limited), Riyas Chelery (Carpel Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available